Viewing StudyNCT05422508



Ignite Creation Date: 2024-05-06 @ 5:45 PM
Last Modification Date: 2024-10-26 @ 2:35 PM
Study NCT ID: NCT05422508
Status: RECRUITING
Last Update Posted: 2024-01-24
First Post: 2022-05-24

Brief Title: Evaluate the Safety and Immunogenicity After MG1111BARICELA Inj as 2nd Vaccination in 4 6 Year Old Healthy Children With a History of 1st Varicella Vaccination
Sponsor: Green Cross Corporation
Organization: GC Biopharma Corp

Key Dates - Follows AllAPIJSON File Order

Start Date: 2022-07-05
Start Date Type: ACTUAL
Primary Completion Date: 2025-06
Primary Completion Date Type: ESTIMATED
Completion Date: 2027-06
Completion Date Type: ESTIMATED
First Submit Date: 2022-05-24
First Submit QC Date: June 14 2022
Study First Post Date: 2022-06-16
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-01-23
Last Update Post Date: 2024-01-24
Last Update Post Date Type: ACTUAL